S.G.P.

New infarction epidemiology research from Eastern Piedmont University, Division of Cardiology described.
Heart Disease Weekly; 12/13/2009; 1134 words; ...relationship between patient's risk profile and benefits...inhibitors in terms of death (p=0.008) but not re-infarction (p=0.25). This meta-analysis...IIIa inhibitors and patient's risk profile," wrote Luca G. De and colleagues, Eastern...

New science study findings have been reported by scientists at Carleton University.
NewsRx Health & Science; 12/13/2009; 1086 words; ...Singh, A.; Jyothi. G.; Easwaran, K. R. K...Heintz, A. M.; Hsu, S. L.; Gido, S. P.; Penelle, J. Polym...of organo gels," wrote S. Khanna and colleagues...more information, contact P. Sundararajan, Carleton...

Control of blood clotting by platelets described; provides medical promise.
NewsRx Health & Science; 12/13/2009; 826 words; ...saving magic in the November 24 (8 p.m. Eastern U.S. Time) online issue of the journal...Drahos, biological sciences Master's degree student from Roanoke, Va...Carla V. Finkielstein and Daniel G. S. Capelluto. Capelluto and Finkielstein...

SGLP Announces Close of Vitol Transaction and Reorganization of Board and Management Team.
Resource Week; 12/13/2009; 1594 words; ...Energy Partners, L.P. ("SGLP") (Pink...SemGroup Energy Partners G.P., L.L.C., SGLP's general partner...Energy Partners, L.P. effective December...Vitol, Inc.'s President, stated...Ahmed, Christopher G. Brown, James C...

Investigators at Ruhr University have published new data on hyperemia.
Heart Disease Weekly; 12/13/2009; 906 words; ...vein at a dose of 140 mu g kg(-1) min(-1...than compared with A170 (P = 0.038) and F140 (P = 0.005). No significant...antecubital dosage of 170 mu g kg(-1) min(-1) is...Germany. The publisher's contact information for...